
- Partner With A Results-Driven Organization…
- Since 1955, the mission of the Cystic Fibrosis Foundation is to assure the development of the means to cure and control cystic fibrosis (CF) and to improve the quality of life for those with the disease. The CF Foundation tirelessly pursues its mission by supporting scientific research, which is dedicated to the discovery and development of new therapies. At the same time, it funds and accredits a network of specialized treatment centers that provide state-of the-art care for people with CF. By applying the same principles that a “for-profit company” follows—efficiency, innovation and a results-driven approach—the CF Foundation is making a profound difference in the lives of those with CF.
- The CF Foundation Is Efficient
- The CF Foundation has been recognized by publications such as SmartMoney as one of the most efficient organizations of its kind. Nearly 90 cents of every dollar of revenue raised is available for investment in vital CF programs to support research, care and education.
- The CF Foundation Is Innovative
- The CF Foundation has adopted an innovative business approach to drug discovery and development that is emulated by other nonprofits. This approach has been widely recognized by organizations including National Institutes of Health and publications such as Forbes and USA Today.
- The CF Foundation Is Results-Driven
- When the CF Foundation began, few children lived to attend elementary school. Thanks to the research and care supported by the CF Foundation, the median age of survival for a person with CF is now 37 years.
- The CF Foundation Needs Your Help!
- Although the outlook for a child born with CF today has improved tremendously over the years, it is not good enough. Your involvement and financial support are critical to our success. Working together, we can add tomorrows every day to the lives of all people with CF. To become involved, please call 1-800-FIGHTCF and ask to be connected to your local chapter.

Download Sponsorship Proposal- IMPORTANT: This download requires Adobe Reader to view its contents.




